Profiel
Kenneth F.
Miller served as President, Chief Executive Officer & Director at BioVentrix, Inc. from 2012 to 2021.
Prior to that, he was the Chief Operating Officer at R2 Technology, Inc. from 2000 to 2004.
He also held the position of Vice President-Sales & Marketing at Cholestech Corp.
and Vice President-Sales at CareFusion 303, Inc. Mr. Miller received an undergraduate degree from Rutgers State University of New Jersey and an MBA from Fairleigh Dickinson University.
Eerdere bekende functies van Kenneth F. Miller
| Bedrijven | Functie | Einde |
|---|---|---|
BioVentrix, Inc.
 BioVentrix, Inc. Medical SpecialtiesHealth Technology BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA. | Algemeen Directeur | 29-04-2021 |
R2 Technology, Inc.
 R2 Technology, Inc. Medical SpecialtiesHealth Technology R2 Technology, Inc. develops and commercializes computer aided detection (CAD). The company also offers CAD systems for a variety of imaging modalities and disease states. The firm was founded in May, 1993 by S.P. Bob Wang and is headquartered in Santa Clara, CA. | Operationeel Directeur | 01-03-2004 |
CareFusion 303, Inc.
 CareFusion 303, Inc. Medical SpecialtiesHealth Technology CareFusion 303, Inc. designs, makes and distributes infusion therapy and vital signs measurement instruments. The company operates manufacturing facilities in the United States, Mexico and the United Kingdom. The firm was founded in 1988 and is headquartered in San Diego, CA. | Verkoop & Marketing | 01-10-1999 |
Cholestech Corp.
 Cholestech Corp. Medical SpecialtiesHealth Technology Cholestech Corp. provides diagnostic tools and information for risk assessment and therapeutic monitoring of heart disease, inflammatory disorders, and diabetes. It manufactures LDX System, multi-analytic testing system, and accessories to perform individual tests. The company was founded in 1988 and is headquartered in Hayward, CA. | Verkoop & Marketing | - |
Opleiding van Kenneth F. Miller
| Rutgers State University of New Jersey | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Cholestech Corp.
Cholestech Corp. Medical SpecialtiesHealth Technology Cholestech Corp. provides diagnostic tools and information for risk assessment and therapeutic monitoring of heart disease, inflammatory disorders, and diabetes. It manufactures LDX System, multi-analytic testing system, and accessories to perform individual tests. The company was founded in 1988 and is headquartered in Hayward, CA. | Health Technology |
R2 Technology, Inc.
R2 Technology, Inc. Medical SpecialtiesHealth Technology R2 Technology, Inc. develops and commercializes computer aided detection (CAD). The company also offers CAD systems for a variety of imaging modalities and disease states. The firm was founded in May, 1993 by S.P. Bob Wang and is headquartered in Santa Clara, CA. | Health Technology |
CareFusion 303, Inc.
CareFusion 303, Inc. Medical SpecialtiesHealth Technology CareFusion 303, Inc. designs, makes and distributes infusion therapy and vital signs measurement instruments. The company operates manufacturing facilities in the United States, Mexico and the United Kingdom. The firm was founded in 1988 and is headquartered in San Diego, CA. | Health Technology |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA. | Health Technology |
